Kodu・Aktsiate loetelu・ResMed Inc

ResMed Inc

Suletud

SektorTervishoid

211.83 -4.93

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

202

Max

222.61

Põhinäitajad
By Trading Economics
Sissetulek	6.1M 399M
Müük	8.6M 1.4B
P/E Sektori keskmine	20.731 68.51
Aktsiakasum	2.86
Dividenditootlus	1.1
Kasumimarginaal	27.856
Töötajad	10,600
EBITDA	17M 584M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+6.57% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	1.10% 2.29%
Järgmine tulemuste avaldamine	29. okt 2026
Järgmine dividendimakse kuupäev	24. sept 2026
Järgmine aktsia dividendi kuupäev (ex-date)	20. aug 2026

Turustatistika
By TradingEconomics
Turukapital	-1.1B 31B
Eelmine avamishind	216.76
Eelmine sulgemishind	211.83

ResMed Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. aug 2026, 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6. aug 2026, 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5. aug 2026, 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4. aug 2026, 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

3. aug 2026, 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

31. juuli 2026, 21:01 UTC

Resmed Inc shares advanced in after-market trading, significantly above their 20-day moving average. No specific news was identified to explain the increase.

30. juuli 2026, 19:55 UTC

ResMed Inc's shares are declining today, diverging from a broader tech recovery. No specific news was identified to explain the move.

29. juuli 2026, 19:04 UTC

ResMed Inc's shares are higher Wednesday, reflecting overall upward momentum since Tuesday's close, despite a recent pullback from session highs.

28. juuli 2026, 19:02 UTC

Shares of Resmed Inc. are higher today, driven by gains in Health Care Equipment stocks. No specific news was identified to explain this increase.

27. juuli 2026, 22:26 UTC

Resmed Inc shares are trading higher in after-hours activity, remaining above their 20-day moving average despite no specific news driving the price movement.

24. juuli 2026, 16:03 UTC

ResMed Inc shares are higher today, driven by gains in the Health Care Equipment sub-sector, despite earlier volatility and recent underperformance.

22. juuli 2026, 23:16 UTC

Resmed Inc shares are trading higher in after-market hours, rebounding from an initial dip and showing unusual strength compared to typical performance.

21. juuli 2026, 20:56 UTC

Resmed Inc. shares are trading roughly flat after-market, amid broader market optimism following positive earnings from 3M and General Motors.

20. juuli 2026, 19:16 UTC

ResMed Inc shares are lower today, continuing a downward trend since Friday. The stock briefly hit a session high earlier but has since declined.

Võrdlus sarnastega

Hinnamuutus

ResMed Inc Prognoos

Hinnasiht

By TipRanks

6.57% tõus

12 kuu keskmine prognoos

Keskmine 237.91 USD 6.57%

Kõrge 320 USD

Madal 213 USD

Põhineb 14 Wall Streeti analüütiku instrumendi ResMed Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

Osta

Hoia

Müü

Põhineb 14 analüütiku instrumendi ResMed Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.